These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

455 related articles for article (PubMed ID: 27933485)

  • 1. Fluid-Based Biomarkers for Amyotrophic Lateral Sclerosis.
    Vu LT; Bowser R
    Neurotherapeutics; 2017 Jan; 14(1):119-134. PubMed ID: 27933485
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elevated levels of ferritin in the cerebrospinal fluid of amyotrophic lateral sclerosis patients.
    Zheng Y; Gao L; Wang D; Zang D
    Acta Neurol Scand; 2017 Aug; 136(2):145-150. PubMed ID: 27804118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biomarker-based predictive models for prognosis in amyotrophic lateral sclerosis.
    Su XW; Simmons Z; Mitchell RM; Kong L; Stephens HE; Connor JR
    JAMA Neurol; 2013 Dec; 70(12):1505-11. PubMed ID: 24145899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neurofilament Subunit L Levels in the Cerebrospinal Fluid and Serum of Patients with Amyotrophic Lateral Sclerosis.
    Gong ZY; Lv GP; Gao LN; Lu Y; Guo J; Zang DW
    Neurodegener Dis; 2018; 18(2-3):165-172. PubMed ID: 29898446
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis.
    Abu-Rumeileh S; Vacchiano V; Zenesini C; Polischi B; de Pasqua S; Fileccia E; Mammana A; Di Stasi V; Capellari S; Salvi F; Liguori R; Parchi P;
    J Neurol; 2020 Jun; 267(6):1699-1708. PubMed ID: 32100123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of cystatin C levels in the cerebrospinal fluid of patients with amyotrophic lateral sclerosis.
    Ren Y; Zhu W; Cui F; Yang F; Chen Z; Ling L; Huang X
    Int J Clin Exp Pathol; 2015; 8(5):5419-26. PubMed ID: 26191245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inflammatory markers in cerebrospinal fluid: independent prognostic biomarkers in amyotrophic lateral sclerosis?
    Gille B; De Schaepdryver M; Dedeene L; Goossens J; Claeys KG; Van Den Bosch L; Tournoy J; Van Damme P; Poesen K
    J Neurol Neurosurg Psychiatry; 2019 Dec; 90(12):1338-1346. PubMed ID: 31175169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neurofilaments as Biomarkers for Amyotrophic Lateral Sclerosis: A Systematic Review and Meta-Analysis.
    Xu Z; Henderson RD; David M; McCombe PA
    PLoS One; 2016; 11(10):e0164625. PubMed ID: 27732645
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amyotrophic Lateral Sclerosis (ALS) prediction model derived from plasma and CSF biomarkers.
    Khosla R; Rain M; Sharma S; Anand A
    PLoS One; 2021; 16(2):e0247025. PubMed ID: 33606761
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluid biomarkers for amyotrophic lateral sclerosis: a review.
    Irwin KE; Sheth U; Wong PC; Gendron TF
    Mol Neurodegener; 2024 Jan; 19(1):9. PubMed ID: 38267984
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phosphorylated neurofilament heavy subunit (pNF-H) in peripheral blood and CSF as a potential prognostic biomarker in amyotrophic lateral sclerosis.
    Boylan KB; Glass JD; Crook JE; Yang C; Thomas CS; Desaro P; Johnston A; Overstreet K; Kelly C; Polak M; Shaw G
    J Neurol Neurosurg Psychiatry; 2013 Apr; 84(4):467-72. PubMed ID: 23117489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid levels of chromogranin A and phosphorylated neurofilament heavy chain are elevated in amyotrophic lateral sclerosis.
    Kaiserova M; Grambalova Z; Otruba P; Stejskal D; Prikrylova Vranova H; Mares J; Mensikova K; Kanovsky P
    Acta Neurol Scand; 2017 Oct; 136(4):360-364. PubMed ID: 28185258
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers for amyotrophic lateral sclerosis.
    Bowser R; Cudkowicz M; Kaddurah-Daouk R
    Expert Rev Mol Diagn; 2006 May; 6(3):387-98. PubMed ID: 16706741
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A CSF biomarker panel for identification of patients with amyotrophic lateral sclerosis.
    Mitchell RM; Freeman WM; Randazzo WT; Stephens HE; Beard JL; Simmons Z; Connor JR
    Neurology; 2009 Jan; 72(1):14-9. PubMed ID: 18987350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma and cerebrospinal fluid-based protein biomarkers for motor neuron disease.
    Kolarcik C; Bowser R
    Mol Diagn Ther; 2006; 10(5):281-92. PubMed ID: 17022691
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chitinases as a potential diagnostic and prognostic biomarker for amyotrophic lateral sclerosis: a systematic review and meta-analysis.
    Xu A; Luo Y; Tang Y; Yang F; Gao X; Qiao G; Zhu X; Zhou J
    Neurol Sci; 2024 Jun; 45(6):2489-2503. PubMed ID: 38194198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessment of a multiple biomarker panel for diagnosis of amyotrophic lateral sclerosis.
    Chen X; Chen Y; Wei Q; Ou R; Cao B; Zhao B; Shang HF
    BMC Neurol; 2016 Sep; 16():173. PubMed ID: 27634542
    [TBL] [Abstract][Full Text] [Related]  

  • 18. UCHL1 from serum and CSF is a candidate biomarker for amyotrophic lateral sclerosis.
    Li R; Wang J; Xie W; Liu J; Wang C
    Ann Clin Transl Neurol; 2020 Aug; 7(8):1420-1428. PubMed ID: 32729234
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [A prognostic biomarker in amyotrophic lateral sclerosis].
    Mitsumoto H; Saito T
    Rinsho Shinkeigaku; 2018 Dec; 58(12):729-736. PubMed ID: 30487362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cystatin C: a candidate biomarker for amyotrophic lateral sclerosis.
    Wilson ME; Boumaza I; Lacomis D; Bowser R
    PLoS One; 2010 Dec; 5(12):e15133. PubMed ID: 21151566
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.